Petition  seeks comprehensive policy on production, supply and sale of healthy, hygienic and natural milk The Supreme Court on May 9 sought a response from the apex food body, the Food Safety and Standards Authority of India (FSSAI), and the states regarding milk adulteration and production of synthetic milk. The three-judge bench sought their response on the public interest petition filed by Swami Achyutanand Tirth on behalf of the Swami Bhumanand...

Human rights commission calls for collective efforts to provide healthcare, compensation to victims and kin The National Human Rights Commission has slammed the Centre and state governments for neglecting workers who are suffering from silicosis—an incurable lung disease caused due to inhalation of silica in dust. The reprimand is in the form of a note that followed the commission's fourth review meeting in New Delhi that concluded on May 4. Over...

New census data on asset ownership among different social groups has shown that a far higher proportion of scheduled castes and higher still of scheduled tribes do not own basic consumer durables like a phone or bicycle as compared to "others". Three states however buck this trend; across caste groupings in Punjab, Kerala and Tamil Nadu, the rate of ownership of basic consumer durables is high. In fact, the asset ownership...

When a corporate executive recently landed in the emergency ward of Hiranandani Hospital in Powai with palpitations, doctors first checked his heart. When tests ruled out any cardiac problem, they found an unlikely culprit-too many cups of green tea. "After talking to him, we realized he had had over a dozen cups of green tea within the span of a few hours,'' said cardiologist Ganesh Kumar. Some brands of green tea...

Fighting cancer has just become less expensive for millions of Indian patients. More than 12 years after he electrified the pharma industry by taking on powerful global giants in his quest to supply cheap anti-AIDS drugs, Cipla promoter YK Hamied is back donning the role of a price warrior. This time, his attention is on anti-cancer drugs. On Thursday, Cipla cut prices of key cancer drugs by nearly 75%, an astounding,...